-
-
-
-
-
-
-
Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
-
-
-
-
-
-
-
Bicara Therapeutics (BCAX) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Bicara Therapeutics Inc (BCAX) PT Raised to $42 at H.C. Wainwright
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)
-
-
-
-
-
-
-
Bicara Therapeutics Inc. (BCAX) Reports Q3 Loss of $0.67
-
-
-
-
-
-
-
Bicara Therapeutics Inc (BCAX) PT Lowered to $40 at H.C. Wainwright
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)
-
483,834 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


